Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Daniela Frimmer1, Katharina Buerger1,2

  • 1Institut für Schlaganfall- und Demenzforschung, LMU Klinikum München.

Fortschritte Der Neurologie-Psychiatrie
|July 20, 2022
PubMed
Summary
This summary is machine-generated.

Cognitive interventions (CI) offer non-pharmacological treatment for Alzheimer's disease (AD). This review explores their background, effectiveness across AD stages, and future applications, including digital options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smartphone-based detection of subtle memory decline in prodromal Alzheimer's disease.

NPJ digital medicine·2026
Same author

Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment.

The journal of prevention of Alzheimer's disease·2026
Same author

Minor neuropsychological deficits and stage 2 of Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Non-economic social deprivation and cognitive functioning later in life: Results from the DELCODE study.

Journal of Alzheimer's disease : JAD·2026
Same author

Pathways to resilience: relationships between cognitive reserve, psychological debt, and Alzheimer's disease biomarkers.

Alzheimer's research & therapy·2026
Same author

GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy.

Nature communications·2026
Same journal

[Digital transformation in multiple sclerosis: Advances in diagnostics, monitoring and patient-centred care].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Dementia with Lewy bodies].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Impact of the PEPP reimbursement system and other developments on inpatient care of general psychiatry patients 2005 to 2022: a retrospective analysis].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[The pathology of the brain eating amoeba Naegleria fowleri].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Chronic vestibular syndromes: Correct diagnosis and treatment].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Lithium: A "Never‑Ending Story" - Now for Dementia Prevention?]

Fortschritte der Neurologie-Psychiatrie·2026
See all related articles

Area of Science:

  • Neurology
  • Gerontology
  • Psychology

Background:

  • Alzheimer's disease (AD) management includes non-pharmacological approaches.
  • Cognitive interventions (CI) are a key component of AD care.
  • CI can be tailored to individual patient needs and symptoms.

Purpose of the Study:

  • To provide a comprehensive overview of cognitive interventions for Alzheimer's disease.
  • To examine the theoretical underpinnings and empirical evidence of CI efficacy.
  • To discuss factors influencing CI effectiveness and clinical utility.

Main Methods:

  • Literature review of cognitive interventions in Alzheimer's disease.
  • Analysis of theoretical frameworks supporting CI.
  • Synthesis of empirical studies on CI efficacy at various disease stages.

Related Experiment Videos

Main Results:

  • Cognitive interventions show varied efficacy depending on the stage of Alzheimer's disease.
  • Effectiveness is influenced by specific determinants, which are discussed.
  • Recent advancements, including computer-based CI, are emerging.

Conclusions:

  • Cognitive interventions are a valuable, adaptable part of Alzheimer's disease treatment.
  • Understanding determinants of effectiveness can optimize clinical application.
  • Future directions include the integration of technology in CI for AD.